Quentin Van Thillo; Cedric Hermans/LinkedIn
Nov 7, 2025, 03:20
Insights on Rebalancing Agents in Hemophilia from Cédric Hermans and Quentin Van Thillo
World Federation of Hemophilia (WFH) shared on LinkedIn:
”Rebalancing agents are reshaping hemophilia treatment—but key questions remain.
What do we know, where are the uncertainties, and how do we move forward responsibly?”
Read the full article in Haematologica.
Article: Rebalancing agents in hemophilia: knowns, unknowns, and uncertainties
Authors: Quentin Van Thillo, Cédric Hermans
Stay updated on all scientific advances with Hemostasis Today.
-
May 7, 2026, 12:56Ash Wallington: Why Are We Throwing Away 97% of the Cure?
-
May 7, 2026, 12:44Swati Bhayana: Restless Leg Syndrome in Thalassemia Major
-
May 7, 2026, 12:41Kathleen Bogart: Did You Know May Is Fanconi Anemia Awareness Month?
-
May 7, 2026, 12:39Michael Cahillane: Highlights of a New Approach to Platelet Efficiency at ISBT
-
May 7, 2026, 11:39Flora Peyvandi: Systematic Review of Genetic Findings in TTP
-
May 7, 2026, 11:03Ney Carter Borges: Oral Semaglutide and Cardiovascular Risk Factors in the SOUL Trial
-
May 7, 2026, 11:01Daniel Ben-Mordechay: Portal Vein Thrombosis – Ultrasound Perspective
-
May 7, 2026, 07:48Could Albuminuria Be an Overlooked Marker of Thrombotic Risk? – RPTH Journal
-
May 7, 2026, 07:37Matías J Alet: On the Implementation of Tenecteplase for Acute Ischemic Stroke at ESOC 2026